BUSINESS (Details Narrative) |
Jul. 28, 2016 |
---|---|
BioCorRx Pharmaceuticals [Member] | |
Equity issued ownership | 75.80% |
BioCorRx Pharmaceuticals, Inc [Member] | |
Management fee | 65.00% |
Non-Controlling Interest [Member] | |
Equity issued ownership | 24.20% |
X | ||||||||||
- Definition Percentage of assumed life insurance contract issued and outstanding to life insurance contract issued and outstanding after effect of reinsurance, as disclosed in supplementary reinsurance information. Includes, but is not limited to, dividend and adjustment to face value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|